Medical Conference Calendar 2026–2027
Key venues for Phase 2/3 trial readouts, late-breaking data, and FDA decisions · 51 upcoming conferences through 2027
Key presentations tracked as they happen
Curated selection of key Phase 2/3 readouts and late-breaking abstracts from major pharma (not a complete list). Currently tracking 7 presentations across 5 conferences so far.
November 2026
Neuro-oncology — glioblastoma, brain metastases, CNS lymphoma. CAR-T in GBM, checkpoint inhibitors in CNS tumors. Roche, Merck, BMS, AstraZeneca, emerging CAR-T programs.
Premier obesity clinical science conference. GLP-1 revolution: semaglutide, tirzepatide secondary analyses, real-world data, new obesity drugs. Novo Nordisk, Eli Lilly, AstraZeneca, Pfizer, Roche obesity programs.
The primary conference for Alzheimer's clinical trial readouts. Distinct from AD/PD (which is broader). Biogen/Eisai (lecanemab), Eli Lilly (donanemab), Roche (gantenerumab), Merck, Novo Nordisk CNS programs present here.
Early-phase oncology and novel-target data (first-in-human, ADCs, targeted agents). Held at Barcelona International Convention Centre (CCIB). Alternates Europe/US yearly (US-hosted years are titled AACR-NCI-EORTC).
December 2026
Largest US epilepsy meeting; antiseizure drugs, genetic epilepsies, neuromodulation. Venue building not stated on pages fetched.
Asia-Pacific oncology congress; frequent venue for China/Asia-originated assets and regional subgroup data. Venue building not stated on page.
Largest breast cancer research meeting. Venue: Henry B. Gonzalez Convention Center. Late-breaking abstract deadline Sept 30, 2026. Held in partnership with AACR.
Key venue for leukemia, lymphoma, myeloma, and blood disorder data.
January 2027
45th annual. Invitation-only healthcare investment symposium; biotech/pharma corporate updates, guidance and deal announcements. No scientific abstracts. Not disease-specific, so therapeuticAreas left empty (no 'All' value exists in file). Venue not stated on official page.
Venue: Moscone West. Late-breaking abstract deadline Oct 22, 2026.
February 2027
Lysosomal storage disorders — Gaucher, Fabry, Pompe, Niemann-Pick, MPS. 23rd annual meeting; The Patient Voice session Jan 31, 2027 precedes the Feb 1-4 research meeting.
Venue: Moscone West. Late-breaking abstract deadline Nov 12, 2026.
Key US venue for stem-cell transplant, CAR-T and cell/gene therapy outcomes. Held at Orlando World Center Marriott. Abstract deadline (Oct. 9) has passed.
Asthma, allergy, immunodeficiency. Biologics for severe asthma and atopic dermatitis. Venue: Ernest N. Morial Convention Center. General abstract deadline not shown; timeline lists 'Discovery Abstract Submission Deadline' and 'Late Breaking Abstract Deadline' both 2 November (2026).
28th European Congress on Gynaecological Oncology. Venue: ExCeL London. LBA deadline Jan 15, 2027.
March 2027
IBD-focused European meeting. Early data for UC and Crohn's often presented here.
Diabetes technology and therapeutics (CGM, AID systems, insulins, incretins). Venue building not stated on homepage.
North American MS meeting (BTK inhibitors, CD20, remyelination). Venue building not stated on homepage.
Alzheimer's disease and Parkinson's disease. Early-stage data and biomarkers. Regular abstract deadline not shown; late-breaking submission opens Nov 18, 2026, deadline Dec 2, 2026. Venue building not stated on site.
World's largest dermatology meeting. Key for atopic dermatitis, psoriasis, hidradenitis suppurativa, alopecia areata. Venue not stated on the AAD pages checked. Abstract deadline is for Poster Exhibit / symposia submissions; late-breaking research opens Fall 2026.
Renamed from 'Annual Meeting on Women's Cancer'. Venue and abstract deadline not found on official site.
April 2027
Venue: Orange County Convention Center. Late-breaking/clinical trials abstract deadline Jan 6, 2027.
Largest European infectious-disease/microbiology congress; antibiotics, antifungals, vaccines, AMR. Venue building not stated on page.
Premier US cardiology meeting. Late-breaking trials in heart failure, CAD, lipids. 2027 edition held together with the World Heart Federation's World Congress of Cardiology (ACC.27-WCC).
Europe's largest transplantation, cellular and gene therapy congress (53rd meeting). Venue: Rotterdam Ahoy.
May 2027
MS, Alzheimer's, Parkinson's, epilepsy, stroke neurology. Regular abstract deadline was in October 2026 (exact date not published on current page); Late-breaking Science deadline February 10, 2027.
Premier US psychiatry meeting. General abstract deadline not shown; the 2027 Clinical Trials Plenary submission site closes Friday, January 8 (2027) at 2:00 p.m. ET. Venue building not stated.
Primary venue for gene therapy, gene editing and cell therapy data (AAV, CRISPR, CAR-T, in vivo editing). Venue building not stated on the official page.
COPD, asthma, IPF, PAH, lung cancer. Key for biologics like dupilumab, tezepelumab. Venue not stated on official site.
IBD (Crohn's, UC), liver disease, GI oncology. Venue: Walter E. Washington Convention Center. Late-breaking abstracts Mar 10–17, 2027.
Lipid disorders, atherosclerosis, PCSK9 inhibitors, ANGPTL3, Lp(a) therapies. 95th EAS Congress.
June 2027
European nephrology. CKD, IgA nephropathy, glomerulonephritis, dialysis. 64th ERA Congress, Rotterdam & virtual. Venue not stated on official page.
Largest oncology conference. Major readouts for solid tumors, immunotherapy, hematologic cancers. Venue: McCormick Place. 2027 abstract dates to be posted in early November 2026.
Hormonal disorders, thyroid, adrenal, obesity, growth disorders.
Sleep disorders — insomnia, OSA, narcolepsy, idiopathic hypersomnia.
European rheumatology and musculoskeletal disease. Often TNF, IL-6, JAK data. Venue: Messe Berlin.
Premier European hematology congress, complements ASH. Venue: Fira Barcelona Gran Via. Late-breaking abstracts Apr 30 - May 6, 2027.
MASH/NAFLD, viral hepatitis B/D/C, liver fibrosis, cirrhosis, HCC. European counterpart to AASLD. Venue: ExCeL London.
Key for GLP-1 agonists, insulin, SGLT2 inhibitors, obesity drugs.
Thrombosis, hemostasis, bleeding disorders. Hemophilia (gene therapy, fitusiran, emicizumab), VTE, anticoagulation.
July 2027
Largest dementia-research congress; key venue for anti-amyloid/anti-tau and blood-biomarker data. Abstract submissions open fall 2026 (deadline not yet published).
August 2027
European cardiovascular data. Often presents pivotal cardiovascular outcomes trials.
September 2027
European respiratory. IPF, asthma, COPD, lung cancer readouts. Venue: Allianz MiCo, Milan.
Venue not yet named on official site. Abstract deadline not yet published.
Venue: Fira Barcelona Gran Via. Abstract deadline not yet published.
40th ECNP Congress. Europe's largest applied neuroscience and psychiatry meeting. Abstract deadline not yet published.
October 2027
Premier US clinical GI meeting (IBD, GERD, liver, GI oncology). City/venue for 2027 not yet published (gi.org future-annual-meeting-dates says 'Please check back'). Dates span includes Postgraduate Course.
November 2027
Largest US ophthalmology conference. Subspecialty Day Nov 12-13, Expo Nov 13-15. Abstract deadline not found on site.
December 2027
Largest breast cancer research meeting. Venue: Henry B. Gonzalez Convention Center (per symposium overview). Abstract deadline not yet published.
Key Presentations
Curated selection of 7 notable readouts (not comprehensive)
Earlier in 2026
2025 Conference Archive
41 conferences — dates, locations, and presentations
Matching trial readouts to conferences
When a Phase 2 or Phase 3 trial's Primary Completion Date falls in the months before a major conference in the same disease area, that conference is the most likely venue for the readout.
| Disease area | Primary readout venue | Abstract window |
|---|---|---|
| Solid tumors | ASCO (Jun), ESMO (Sep) | Jan–Feb for ASCO; Apr–May for ESMO |
| Hematology | ASH (Dec), ASCO (Jun) | Jun for ASH; Jan–Feb for ASCO |
| Cardiovascular | ACC (Mar), AHA (Nov), ESC (Aug) | Oct for ACC; Apr for ESC |
13 more disease areas
Unlock with Pro · $99/mo →